Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Assets: 2009-2025

Historic Current Assets for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $29.9 million.

  • Cumberland Pharmaceuticals' Current Assets fell 15.03% to $29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year decrease of 15.03%. This contributed to the annual value of $36.5 million for FY2024, which is 2.07% up from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Current Assets of $29.9 million as of Q3 2025, which was down 4.06% from $31.2 million recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Current Assets' 5-year high stood at $49.4 million during Q1 2021, with a 5-year trough of $29.9 million in Q3 2025.
  • Moreover, its 3-year median value for Current Assets was $35.7 million (2023), whereas its average is $36.5 million.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Current Assets increased by 10.39% in 2021 and then dropped by 22.14% in 2023.
  • Over the past 5 years, Cumberland Pharmaceuticals' Current Assets (Quarterly) stood at $45.7 million in 2021, then climbed by 0.40% to $45.9 million in 2022, then fell by 22.14% to $35.7 million in 2023, then climbed by 2.07% to $36.5 million in 2024, then fell by 15.03% to $29.9 million in 2025.
  • Its last three reported values are $29.9 million in Q3 2025, $31.2 million for Q2 2025, and $31.9 million during Q1 2025.